Group One Trading
BDTX icon

Group One Trading’s Black Diamond Therapeutics BDTX Stock Holding History

Group One Trading’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.3K Buy
45,200
+8,600
+23% +$20.5K ﹤0.01% 4771
2025
Q4 		$88.9K Buy
36,600
+10,400
+40% +$36.8K ﹤0.01% 5097
2025
Q3 		$99.3K Buy
26,200
+17,500
+201% +$51.2K ﹤0.01% 5357
2025
Q2 		$21.6K Sell
8,700
-900
-9% -$1.74K ﹤0.01% 6214
2025
Q1 		$14.9K Buy
9,600
+9,300
+3,100% +$19.5K ﹤0.01% 6010
2024
Q4 		$642 Sell
300
-31,500
-99% -$90.3K ﹤0.01% 6969
2024
Q3 		$138K Buy
+31,800
New +$173K ﹤0.01% 3921
2024
Q2 		– Sell
-16,600
Closed -$84.2K – 6720
2024
Q1 		$84.2K Sell
16,600
-12,900
-44% -$52K ﹤0.01% 4287
2023
Q4 		$82.9K Sell
29,500
-57,900
-66% -$136K ﹤0.01% 4616
2023
Q3 		$251K Sell
87,400
-89,200
-51% -$329K ﹤0.01% 3607
2023
Q2 		$892K Buy
+176,600
New +$361K ﹤0.01% 2459
2022
Q4 		– Sell
-81,000
Closed -$137K – 7232
2022
Q3 		$137K Buy
81,000
+11,400
+16% +$35.2K ﹤0.01% 4483
2022
Q2 		$171K Buy
69,600
+68,600
+6,860% +$159K ﹤0.01% 4448
2022
Q1 		$3K Buy
1,000
+400
+67% +$1.46K ﹤0.01% 7606
2021
Q4 		$3K Sell
600
-4,700
-89% -$32.8K ﹤0.01% 7759
2021
Q3 		$45K Sell
5,300
-3,600
-40% -$35.5K ﹤0.01% 6618
2021
Q2 		$108K Buy
+8,900
New +$176K ﹤0.01% 5864

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Group One Trading's BDTX Position: Q1 2026 in Review

Group One Trading sold out of Black Diamond Therapeutics (BDTX) in Q1 2026, closing a stake of 1,618 shares — an estimated $3.85K sold.

Group One Trading first reported a position in BDTX in Q2 2021 and held it in 12 quarters. The position peaked at $328K in Q3 2024. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Group One Trading reported no remaining Black Diamond Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 1,618 Black Diamond Therapeutics shares in Q1 2026, an estimated $3.85K.
  • Group One Trading first reported a position in Black Diamond Therapeutics in Q2 2021 and held it in 12 quarters.
  • Group One Trading's Black Diamond Therapeutics position peaked at $328K in Q3 2024.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.